Bcl9 inhibition attenuates pulmonary fibrosis through macrophage phenotype reprogramming
Here, we reported the clinical relevance of B cell lymphoma 9 (BCL9) in patients with PF, proved that BCL9 levels in macrophage were positively correlate with PF pathogenesis.